↓ Skip to main content

Determination of Cefalothin and Cefazolin in Human Plasma, Urine and Peritoneal Dialysate by UHPLC‐MS/MS: application to a pilot pharmacokinetic study in humans

Overview of attention for article published in Biomedical Chromatography, October 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Determination of Cefalothin and Cefazolin in Human Plasma, Urine and Peritoneal Dialysate by UHPLC‐MS/MS: application to a pilot pharmacokinetic study in humans
Published in
Biomedical Chromatography, October 2015
DOI 10.1002/bmc.3622
Pubmed ID
Authors

Suzanne L. Parker, Yarmarly C. Guerra Valero, Darren M. Roberts, Jeffrey Lipman, Jason A. Roberts, Steven C. Wallis

Abstract

An ultra high performance liquid chromatography - tandem mass spectrometry (UHPLC-MS/MS) method for the analysis of cefazolin and cefalothin in human plasma (total and unbound), urine, and peritoneal dialysate has been developed and validated. Total plasma concentrations are measured following protein precipitation and are suitable for the concentration range of 1 to 500 µg/mL. Unbound concentrations are measured from ultra-filtered plasma acquired using Centrifree® devices and are suitable for the concentration range of 0.1 to 500 µg/mL for cefazolin and 1 to 500 µg/mL for cefalothin. The urine method is suitable for a concentration range of 0.1 to 20 mg/mL for cefazolin and 0.2 to 20 mg/mL for cefalothin. Peritoneal dialysate concentrations are measured using direct injection, and are suitable for the concentration range of 0.2 to 100 µg/mL for both cefazolin and cefalothin. The cefazolin and cefalothin plasma (total and unbound), urine and peritoneal dialysate results are reported for recovery, inter-assay precision and accuracy, and the lower limit of quantification, linearity, stability and matrix effects; with all results meeting acceptance criteria. The method was used successfully in a pilot pharmacokinetic study with patients with peritoneal dialysis-associated peritonitis, receiving either intraperitoneal cefazolin or cefalothin. This article is protected by copyright. All rights reserved.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 15%
Other 3 12%
Researcher 3 12%
Student > Doctoral Student 1 4%
Student > Bachelor 1 4%
Other 5 19%
Unknown 9 35%
Readers by discipline Count As %
Medicine and Dentistry 7 27%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Chemistry 2 8%
Psychology 2 8%
Nursing and Health Professions 1 4%
Other 2 8%
Unknown 10 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 September 2015.
All research outputs
#20,000,155
of 24,577,646 outputs
Outputs from Biomedical Chromatography
#975
of 2,050 outputs
Outputs of similar age
#211,896
of 290,189 outputs
Outputs of similar age from Biomedical Chromatography
#12
of 56 outputs
Altmetric has tracked 24,577,646 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,050 research outputs from this source. They receive a mean Attention Score of 2.2. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 290,189 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.